Microparticles and Kawasaki disease: A marker of vascular damage?

Clinical and Experimental Rheumatology

Volumn 29, Issue 1 SUPPL. 64, 2011, Pages

  Guiducci, Serena ^a   Ricci, L ^a   Romano, E ^a   Ceccarelli, C ^a   Distler, J H W ^b,d   Miniati, I ^a   Calabri, G B ^c   Distler, O ^b   Matucci Cerinic, M ^a   Falcini, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Kawasaki disease; Microparticles

Indexed keywords

B LYMPHOCYTE ANTIBODY; ENDOTHELIAL CELL ANTIBODY; GRANULOCYTE ANTIBODY; MONOCLONAL ANTIBODY; T LYMPHOCYTE ANTIBODY; THROMBOCYTE ANTIBODY; ACETYLSALICYLIC ACID; CELL ANTIBODY; IMMUNOGLOBULIN; MONOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL INJURY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; STAINING; B LYMPHOCYTE; DISEASE MARKER; ENDOTHELIUM CELL; HUMAN CELL; IMMUNOTHERAPY; LEUKOCYTE MICROPARTICLE; LYMPHOCYTE COUNT; MONOCYTE; MULTIPLE CYCLE TREATMENT; NEUTROPHIL; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PLATELET MICROPARTICLE; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; T LYMPHOCYTE; THROMBOCYTE; TREATMENT RESPONSE;

B-LYMPHOCYTES; BLOOD PLATELETS; CASE-CONTROL STUDIES; CELL-DERIVED MICROPARTICLES; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; ITALY; LINEAR MODELS; MALE; MONOCYTES; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHILS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 79960416767     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. NEWBURGER JW, MASATO T, GERBER MA GEWITZ MH, TONI LY, BURNS JC: COMMITTEE ON RHEUMATIC FEVER, ENDOCARDITIS, AND KAWASAKI DISEASE; COUNCIL ON CARDIOVASCULAR DISEASE IN THE YOUNG; AMERICAN HEART ASSOCIATION: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 2004; 110: 2747-71.
2. CURTIS N: Kawasaki disease. BMJ 1997; 315: 322-3.
3. BURNS JC, GLODE MP: Kawasaki syndrome. Lancet 2004; 364: 533-44.
4. TAUBERT KA: Epidemiology of Kawasaki disease in the United States and worldwide. Prog Pediatr Cardiol 1997; 6: 181-5.
5. TERAI M, SHULMAN ST: Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gammaglobulin dose but independent of salycilate dose. J Pediatr 1997; 131: 888-93.
6. DAJANI AS, TAUBERT KA, GERBER MA et al.: Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776-80.
7. EBERHARD BA, ANDERSON U, LAXER RM, ROSE V, SILVERMAN ED: Evaluation of cytokine response in Kawasaki Disease. Pediatr Infect Dis J 1995; 14: 199-203.
8. NAOE S, TAKAHASHI K, MASUDA H, TANAKA N: Kawasaki disease. With particular emphasis on arterial lesions. Acta Pathol Jpn 1991; 41: 785-97.
9. JEANETTE JC, SCIARROROTA J, TAKAHASHI K: Predominance of monocytes and macrophages in the inflammatory infiltrates of acute Kawasaki disease arteritis. Pediatr Res 2002; 53: 94A.
10. SHULMAN ST, ROWLEY AH: Advances in Kawasaki disease. Eur J Pediatr 2004; 163: 285-91.
11. ROWLEY AH, SHULMAN ST, GARCIA FL et al.: Cloning the arterial IgA antibody response during acute Kawasaki disease. J Immunol 2005; 175: 8386-91.
12. BOWN TJ, CRAWFORD SE, CORNWALL ML, GARCIA F, SHULMAN ST, ROWLEY AH: CD8 T limphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 2000; 182: 1183-91
13. GAVIN PJ, CRAWFORD SE, SHULMAN ST, GARCIA FL, ROWLEY AH: Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler Thromb Vasc Biol 2003; 23: 576-81.
14. ZWAAL RFA, SCHROIT AJ: Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997; 89: 1121-32.
15. DISTLER JHW: Microparticles as regulators of inflammation. Arthritis Rheum 2005; 52: 3337-48.
16. DISTLER JHW, HUBER LC, GAY S, DISTLER O, PISETSKY DS: Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006; 39: 683-90.
17. NAUTA AJ, TROUW LA, DAHA MR et al.: Direct binding of C1q to apoptotic cells and cells blebs induces complements attivation. Eur J Immunol 2002; 32: 1726-36.
18. ROWLEY AH, GONZALES CRUSSI F, GIDDING SS, DUFFY CE, SHULMAN ST: Incomplete Kawasaki Disease with coronary artery involvement. J Pediatr 1987; 110: 409-13.
19. DE ZORZI A, COLAN SD, GAUVREU K, BAKER AL, SUNDEL RP, NEWBURGER JW: Coronary artery dimensions may be misclassified as normal in Kawasaki Disease. J Pediatr 1998; 133: 254-8.
20. DISTLER JH, JUNGEL A , HUBER LC et al.: The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proc Natl Acad Sci USA 2005; 102: 2892-7.
21. JIMENEZ J, JY W, MAURO LM, SODERLAND C, HORSTMAN C, AHN YS: Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003; 109: 175-80.
22. SATTA N, TOTI F, FENGEAS O et al.: Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. Immunol 1994; 153: 3245-55.
23. BOOTH AD, WALLACE S, MCENIERY CM, YASMIN BJ, JAYNE DR, WILKINSON IB: Inflammation and arterial stifness in systemic vasculitis: a model of vascular inflammation. Arthritis Rheum 2004; 50: 581-8.
24. MINAGAR A, JY W, JIMINEZ JJ: Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56: 1319-24.
25. BACON PA: Endothelial cell dysfunction in systemic vasculitis: new developments and therapeutic prospects. Curr Opin Rheumatol 2005; 17: 49-55.
26. COMBES V, SIMON AC, GRAU GE et al.: In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
27. KÜMPERS P, ERDBRÜGGER U, GROSSHEIM M et al.: Endothelial microparticles as a diagnostic aid in Churg-Strauss vasculitis-induced cardiomyopathy. Clin Exp Rheumatol 2008; 26: S86-9.
28. CHEUNG YF, YUNG TC, TAM SC, HO MH, CHAU AK: Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol 2004; 43: 120-4.
29. SENZAKI H, CHEN CH, ISHIDO H et al.: Arterial hemodynamics in patients after Kawasaki disease. Circulation 2005; 111: 2119-25.
30. MALLAT Z, HUGEL B, OHAN J, LESECHE G, FREYSSINET A, TEDGUI A: Shed membrane microparticles with procoagulant potential in human atherosclerotic plaque: a role for apoptosis in plaque thrombogenicity. Circulation 1999; 99: 348-53.
31. BARRY OP, PRATICÒ D, SAVANI RC, FITZGERALD GA: Modulation of Monocyte-Endothelial Cell Interactions by platelet microparticles. J Clin Invest 1998; 102: 136-44.
32. LUQMANI RA, BACON PA, MOOTS RJ et al.: Birmingham Vasculitis Activity Score in systemic necrotizing vasculitis. QJM 1994; 87: 671-8.
33. BROGAN PA, SHAH V, BRACHET C et al.: Endothelial and platelet microparticles in vasculitis of the young. Arthritis Rheum 2004; 50: 927-36.